Inflammation-Targeting Antibody Improves Preterm Birth Outcomes, Prevents Obesity-Linked Liver Disease, Pair of Studies Shows
Two new studies show preterm births and obesity-related liver disease both improve after treatment with this antibody.
Two new studies show preterm births and obesity-related liver disease both improve after treatment with this antibody.